Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Peters

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituentsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Journal of Medicinal Chemistry|August 12, 2025
Discovery and In-Vivo Characterization of K<sub>v</sub>7 Channel Openers through a Phenotypic ApproachRomain Siegrist, Olivier Bezençon, Caroline Deymier, et al.
Zeitschrift Fur Gastroenterologie|May 12, 2021
In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tractSusann Buchheim-Schmidt, Uwe Peters, Cindy Duysburgh, et al.
Journal of Medicinal Chemistry|May 5, 2025
Discovery of a New Class of Orexin 2 Receptor Agonists as a Potential Treatment for NarcolepsyDavide Pozzi, Romain Siegrist, Jens-Uwe Peters, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mglu5 receptor antagonists based on the fenobam structureSimona M Ceccarelli, Georg Jaeschke, Bernd Buettelmann, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Tyramine fragment binding to BACE-1Andreas Kuglstatter, Martin Stahl, Jens-Uwe Peters, et al.
Drug Discovery Today|January 25, 2012
Can we discover pharmacological promiscuity early in the drug discovery process?Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonistsBernd Büttelmann, Jens-Uwe Peters, Simona Ceccarelli, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligandsJens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitorsThomas Lübbers, Markus Böhringer, Luca Gobbi, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituentsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Journal of Medicinal Chemistry|August 12, 2025
Discovery and In-Vivo Characterization of K<sub>v</sub>7 Channel Openers through a Phenotypic ApproachRomain Siegrist, Olivier Bezençon, Caroline Deymier, et al.
Zeitschrift Fur Gastroenterologie|May 12, 2021
In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tractSusann Buchheim-Schmidt, Uwe Peters, Cindy Duysburgh, et al.
Journal of Medicinal Chemistry|May 5, 2025
Discovery of a New Class of Orexin 2 Receptor Agonists as a Potential Treatment for NarcolepsyDavide Pozzi, Romain Siegrist, Jens-Uwe Peters, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mglu5 receptor antagonists based on the fenobam structureSimona M Ceccarelli, Georg Jaeschke, Bernd Buettelmann, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Tyramine fragment binding to BACE-1Andreas Kuglstatter, Martin Stahl, Jens-Uwe Peters, et al.
Drug Discovery Today|January 25, 2012
Can we discover pharmacological promiscuity early in the drug discovery process?Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonistsBernd Büttelmann, Jens-Uwe Peters, Simona Ceccarelli, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligandsJens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitorsThomas Lübbers, Markus Böhringer, Luca Gobbi, et al.
Pageof 5